COURTNEY BERGER: Open Payments
NPI 1558090977 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,700 in 92 payments from 16 companies in 2025. Trend: 2023 $2,052 · 2024 $2,341 · 2025 $1,700
Food & beverage: $1,700
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $259 |
| Novartis Pharmaceuticals Corporation | 23 | $218 |
| Alnylam Pharmaceuticals Inc. | 7 | $163 |
| Merck Sharp & Dohme LLC | 11 | $162 |
| BridgeBio Pharma, Inc. | 3 | $162 |
| AstraZeneca Pharmaceuticals LP | 5 | $157 |
| E.R. Squibb & Sons, L.L.C. | 8 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $108 |
| Amgen Inc. | 3 | $55 |
Products named: LEQVIO, AMVUTTRA, Attruby, Ozempic, JARDIANCE, Wegovy, ELIQUIS, Kerendia.
Industry payments across TN — which companies pay providers there.
